In what is described as a new paradigm to individualize treatment of esophageal and gastroesophageal junction (GEJ) cancers, researchers have shown that positron emission tomography (PET) can help guide chemotherapy decisions for patients and improve outcomes.
http://www.medscape.com/viewarticle/874585
PET Scan to 'Fine Tune' Chemo for Esophageal Cancer